Impax Laboratories Inc (NASDAQ:IPXL)

23.90
Real-Time Quote
 -0.25 / -1.04%
Today’s Change
19.39
Today|||52-Week Range
31.04
-4.93%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$1.7B

Company Description

Impax Laboratories, Inc. is a technology-based specialty pharmaceutical company. It applies formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products. The company operates its business through two reportable divisions: Global and Impax. The Global Division is focused on developing, manufacturing, selling and distributing controlled-release generic versions of selected brand-name pharmaceuticals covering a broad range of therapeutic areas and having technically challenging drug-delivery mechanisms or unique product development formulations. The Impax Division is focused on developing proprietary branded pharmaceutical products for the treatment of CNS disorders, which include epilepsy, migraine, multiple sclerosis and Parkinson's disease, and the promotion of branded pharmaceutical products through its specialty sales force. Impax Laboratories was founded on December 14, 1999 and is headquartered in Hayward, CA.

Contact Information

Impax Laboratories, Inc.
30831 Huntwood Avenue
Hayward California 94544-7905
P:(510) 476-2000
Investor Relations:
(215) 558-4526

Employees

Shareholders

Mutual fund holders49.68%
Other institutional38.99%
Individual stakeholders13.37%

Top Executives

George Frederick WilkinsonPresident & Chief Executive Officer
Bryan M. ReasonsChief Financial Officer & Senior VP-Finance
Jeffrey D. NornholdSenior Vice President-Technical Operations
Mark A. SchlossbergSecretary, Senior Vice President & General Counsel
Michael J. NestorPresident-Impax Pharmaceuticals Division

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.